60 Biggest Movers From Yesterday

Gainers

  • Trillium Therapeutics Inc. TRIL shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
  • Vivos Therapeutics, Inc. VVOS rose 53.7% to settle at $5.90. The FDA granted 510(k) clearance to Vivos Therapeutics’ mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device.
  • Greenpro Capital Corp. GRNQ gained 34.2% to close at $1.02. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X signed a Memorandum of Understanding with Silkwave Holdings to form a joint venture partnership to develop a GEO-LEO integrated satellite Network and services platform.
  • Canoo Inc. GOEV jumped 31.8% to close at $7.79.
  • Pixelworks, Inc. PXLW jumped 29.2% to close at $5.75 following a 25% surge on Friday.
  • Equillium, Inc. EQ gained 26.9% to close at $6.14. Equillium recently announced additional data from the Type A portion of the EQUALISE Phase 1b study of itolizumab in systemic lupus erythematosus (SLE) and lupus nephritis (LN).
  • Support.com, Inc. SPRT rose 26.8% to settle at $11.17.
  • KLX Energy Services Holdings, Inc. KLXE gained 26% to close at $5.77 amid a weaker US dollar.
  • Candel Therapeutics, Inc. CADL jumped 25.9% to close at $7.93. UBS and Jefferies initiated coverage on the stock with a Buy rating.
  • Endo International plc ENDP rose 25.8% to close at $2.68 after dropping 40% on Friday. Endo International, earlier during the month, posted upbeat quarterly results.
  • City Office REIT, Inc. CIO shares surged 24.8% to settle at $16.10 after the company agreed to sell all of its holdings in the Sorrento Mesa submarket of San Diego for $576 million.
  • ABVC BioPharma, Inc. ABVC gained 23.7% to close at $2.51. ABVC BioPharma recently reported Q2 earnings results.
  • CASI Pharmaceuticals, Inc. CASI surged 23.3% to close at $1.59. CASI Pharmaceuticals Chairman & CEO Wei-Wu He acquired a total of 480000 shares at an average price of $1.28.
  • Xeris Pharmaceuticals, Inc. XERS gained 21.4% to close at $2.67 after the company announced FDA approval of its New Drug Application for Gvoke for the treatment of severe hypoglycemia.
  • Biomea Fusion, Inc. BMEA gained 17.7% to settle at $13.15. Biomea Fusion CEO Butler reported the purchase of 204,470 shares at an average price of $16.15 per share in Form 4 filing on Thursday.
  • Vincerx Pharma, Inc. VINC surged 17.5% to close at $13.94. Vincerx Pharma recently posted a Q2 loss of $0.12 per share.
  • Romeo Power, Inc. RMO jumped 17.5% to close at $5.04.
  • CleanSpark, Inc. CLSK gained 17% to settle at $12.62.
  • Flexion Therapeutics, Inc. FLXN jumped 16.7% to close at $5.46.
  • Rekor Systems, Inc. REKR gained 16.4% to settle at $7.81. The company, last week, reported downbeat quarterly results.
  • Icosavax, Inc. ICVX gained 16.3% to settle at $40.25 after multiple firms initiated coverage on the stock with bullish ratings and price targets, respectively.
  • Meta Materials Inc. MMAT surged 16.3% to close at $3.35.
  • Eos Energy Enterprises, Inc. EOSE rose 16.3% to settle at $13.41. EOS Energy Enterprises recently reported worse-than-expected Q2 EPS and sales results.
  • HyreCar Inc. HYRE climbed 16.2% to close at $10.17.
  • Madison Square Garden Entertainment Corp. MSGE gained 16.2% to close at $72.55 after the company reported better-than-expected Q4 sales results.
  • Catabasis Pharmaceuticals, Inc. CATB jumped 16.1% to settle at $8.80.
  • ALX Oncology Holdings Inc. ALXO gained 16.1% to settle at $72.64 in sympathy with Trillium Therapeutics which announced an acquisition by Pfizer Monday.
  • Huaneng Power International, Inc. HNP gained 16% to close at $19.16.
  • Singular Genomics Systems, Inc. OMIC jumped 16% to settle at $16.59.
  • Bicycle Therapeutics plc BCYC gained 16% to close at $33.20. Bicycle Therapeutics, earlier during the month, posted a Q2 loss of $0.74 per share.
  • Nuvation Bio Inc. NUVB rose 15.9% to settle at $9.32.
  • Velodyne Lidar, Inc. VLDR gained 15.8% to close at $7.15 after company founder David Hall called for Chairman Michael Dee and Director Hamid Zarringhalam to resign from the board.
  • NRx Pharmaceuticals, Inc. NRXP rose 15.7% to settle at $13.78.
  • Bristow Group Inc. VTOL climbed 15.3% to close at $30.32.
  • Dynavax Technologies Corporation DVAX gained 14.4% to close at $13.77. Medigen Vaccine Biologics Corporation and Dynavax Technologies announced the rollout of their COVID-19 vaccine, MVC-COV1901, in Taiwan.
  • Doximity, Inc. DOCS rose 14.4% to close at $87.15.
  • NeuroOne Medical Technologies Corporation NMTC gained 14.2% to close at $4.42 after the company reported a strategic partnership with RBC Medical Innovations for Ablation Program.
  • Landmark Infrastructure Partners LP LMRK gained 14.1% to close at $16.16 as the company agreed to be acquired by its sponsor, Landmark Dividend LLC for $16.50 per unit.
  • Couchbase, Inc. BASE gained 14% to close at $42.95.
  • Canaan Inc. CAN rose 13.8% to close at $9.17 in sympathy with the price of Bitcoin.
  • BeyondSpring Inc. BYSI shares gained 13.7% to close at $22.96.
  • Butterfly Network, Inc. BFLY rose 12.7% to settle at $11.46.
  • BioNTech SE BNTX jumped 9.6% to settle at $382.10. The FDA has approved Pfizer and BioNTech’s COVID-19 vaccine, making it the first to receive full FDA approval.
  • Editas Medicine, Inc. EDIT gained 8.3% to close at $65.36 after the company announced it presented data on new SLEEK gene editing technology at the Cold Spring Harbor Laboratory's Genome Engineering: CRISPR Frontiers meeting.
  • Shattuck Labs, Inc. STTK gained 6.5% to close at $21.24.
  • Yunhong CTI Ltd. CTIB gained 5.5% to settle at $1.91. Yunhong CTI recently reported a deal to sell its Flexo Universal Unit for $500,000.
  • PharmaCyte Biotech, Inc. PMCB gained 5.2% to close at $3.66. PharmaCyte Biotech recently announced a $70 million registered direct offering priced at-the-market under Nasdaq rules.

 

Check out these big penny stock gainers and losers

Losers

  • Regencell Bioscience Holdings Limited RGC dripped 28.3% to close at $13.74 on Monday after jumping over 200% on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.
  • MarketWise, Inc. MKTW fell 16.7% to settle at $6.79. Marketwise recently reported Q2 sales of $142.10 million.
  • Staffing 360 Solutions, Inc. STAF shares fell 13% to close at $1.77 after the company announced a 1.36 million share stock offering priced at $2.10 per share.
  • Flora Growth Corp. FLGC fell 12.2% to settle at $11.14. Flora Growth shares surged 44% on Friday after the company reported its financial and operating results for the six months ending June 30, 2021, revealing revenues of over $2 million, compared to revenues of approximately $100 000 in the same period of last year.
  • Mercurity Fintech Holding Inc. MFH dropped 11.7% to settle at $3.01.
  • Airspan Networks Holdings Inc. MIMO fell 10.2% to close at $6.80. Airspan Networks, on Friday, reported Q2 sales of $42.00 million, up from $27.80 million year over year.
  • Evolv Technologies Holdings, Inc. EVLV dropped 10.2% to close at $8.08. The company, last week, reported a wider quarterly loss.
  • XTL Biopharmaceuticals Ltd. XTLB dipped 9.6% to settle at $4.15.
  • Moxian, Inc. MOXC fell 9.4% to settle at $6.36.
  • Century Therapeutics, Inc. IPSC dropped 8.5% to close at $24.06. Century Therapeutics recently posted a Q2 loss of $1.93 a share.
  • Zhihu Inc. ZH fell 8.1% to close at $9.42 after gaining 15% on Friday. The company recently said its revenue rose 144% year-on-year.
  • Eastside Distilling, Inc. EAST fell 7.4% to settle at $2.89. Eastside Distilling recently posted a Q2 loss of $0.14 a share.
  • Yiren Digital Ltd. YRD dropped 5.7% to close at $3.50. The company recently said it swung to a Q2 profit.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasIntegrated Telecommunication ServicesMovers From YesterdayTelecommunication ServicesTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!